Corcept Therapeutics CORT 深 沪
等待开盘 08-14 09:30:00 美东时间
72.80
-0.790
-1.07%
华盛通- 最 高74.535
- 今 开74.00
- 成交量 46.09万股
- 最 低 72.39
- 昨 收 73.59
- 总市值 76.44亿
- 52周最高 117.33
- 市盈率 静 59.12
- 换手率 0.44%
- 52周最低 33.34
- 委 比 -49.50%
- 总股本 1.05亿
- 历史最高 117.33
- 量 比 0.65
- 振 幅 2.91%
- 历史最低 1.27
- 每 手 1
- 风险率 13.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Corcept Therapeutics’ MOMENTUM Study: Assessing Hypercortisolism in Resistant Hypertension
Corcept Therapeutics (($CORT)) announced an update on their ongoing clinical st...
08-08 00:29
A Look at Axsome Therapeutics's Upcoming Earnings Report
Axsome Therapeutics (NASDAQ:AXSM) is preparing to release its quarterly earning...
08-02 01:04
Piper Sandler Maintains Overweight on Corcept Therapeutics, Lowers Price Target to $121
Piper Sandler analyst David Amsellem maintains Corcept Therapeutics (NASDAQ:CORT) with a Overweight and lowers the price target from $131 to $121.
08-01 20:08
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Corcept Therapeutics Advances Long-Term Safety Study of Relacorilant for Cushing Syndrome
Corcept Therapeutics (($CORT)) announced an update on their ongoing clinical st...
07-31 00:20
Here's How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 5 Years
Corcept Therapeutics (NASDAQ:CORT) has outperformed the market over the past 5 ...
07-21 22:30
What's Driving the Market Sentiment Around Corcept Therapeutics?
Corcept Therapeutics's (NYSE:CORT) short percent of float has fallen 9.51% sinc...
07-18 00:00
Corcept seeks FDA approval for ovarian cancer treatment
Corcept Therapeutics (NASDAQ:CORT) has submitted a marketing application to the U.S. FDA for its cortisol modulator, Relacorilant, a drug designed to help patients with ovarian cancer that does not re...
07-14 22:06
Here's How Much $100 Invested In Corcept Therapeutics 20 Years Ago Would Be Worth Today
Corcept Therapeutics (NASDAQ:CORT) has outperformed the market over the past 20...
07-04 22:15
Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Resistant Hypertension
Corcept Therapeutics (($CORT)) announced an update on their ongoing clinical st...
06-27 00:25
